CNTB (Connect Biopharma Holdings) Beginning Cash Position : $106.01 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Connect Biopharma Holdings Beginning Cash Position?

Connect Biopharma Holdings's Beginning Cash Position for the quarter that ended in Jun. 2024 was $106.01 Mil.

Connect Biopharma Holdings's quarterly Beginning Cash Position increased from Jun. 2023 ($79.01 Mil) to Dec. 2023 ($81.61 Mil) and increased from Dec. 2023 ($81.61 Mil) to Jun. 2024 ($106.01 Mil).

Connect Biopharma Holdings's annual Beginning Cash Position increased from Dec. 2021 ($154.80 Mil) to Dec. 2022 ($267.72 Mil) but then declined from Dec. 2022 ($267.72 Mil) to Dec. 2023 ($79.01 Mil).

Connect Biopharma Holdings Beginning Cash Position Historical Data

The historical data trend for Connect Biopharma Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Connect Biopharma Holdings Beginning Cash Position Chart

Connect Biopharma Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

57.40

47.29

154.80

267.72

79.01

Connect Biopharma Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial					254.69	154.60	79.01	81.61	106.01

Connect Biopharma Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Connect Biopharma Holdings Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Connect Biopharma Holdings's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Connect Biopharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Connect Biopharma Holdings Ltd (NAS:CNTB) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

12265 El Camino Real, Suite 350, San Diego, CA, USA, 92130

Website

https://www.connectbiopharm.com

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.